Skip to main content

Find Clinical Trials

Home
Conditions
Lung Diseases, Interstitial

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

725 public trials 132 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Completed

A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

NCT05154240

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: NZCR Ltd Christchurch, New Zealand

View Trial Details

Completed

SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis

NCT03140644

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
Locations: CH de Bobigny, Hôpital Avicenne Bobigny, France

CHU de Brest Brest, France

CH de Lorient Lorient, France

CHU de Nantes Nantes, France

View Trial Details

Completed

The Diagnostic and Prognostic Role of SAA in Intrathoracic Sarcoidosis

NCT05811962

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
Locations: Department of pulmonary diseases and allergy, UMC Ljubljana Ljubljana, Slovenia

View Trial Details

Completed

An RCT of NBI vs. White Light Guided Endobronchial Biopsy in Suspected Sarcoidosis

NCT05311150

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
Locations: Postgraduate Institute of Medical Education and Research Chandigarh, India

View Trial Details

Completed

A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

NCT04720443

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: PAREXEL International Glendale, California, United States

View Trial Details

Completed

Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT

NCT02456246

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis

NCT04280601

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +25 more
Locations: Mount Sinai Hospital, Vasculitis clinic Toronto, Canada

View Trial Details

Completed

FIBRotic Interstitial Lung Disease and Nocturnal OXygen

NCT04586946

Conditions: Apnea, Dyssomnias, Idiopathic Pulmonary Fibrosis, +15 more
Locations: Guy's and St Thomas' NHS Foundation Trust London, United Kingdom

Royal Brompton Hospital London, United Kingdom

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327

NCT04069143

Conditions: Healthy Participants, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), +4 more
Locations: Local Institution - 0001 New Haven, Connecticut, United States

View Trial Details

Completed

Acthar Gel in Participants With Pulmonary Sarcoidosis

NCT03320070

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
Locations: UAB Lung Health Center Birmingham, Alabama, United States

David Geffen School of Medicine Los Angeles, California, United States

National Jewish Health Denver, Colorado, United States

University of Florida Division of Pulmonary, Critical Care, and Sleep Medicine Gainesville, Florida, United States

View all 29 locations

View Trial Details